CHF Solutions, Inc (CHFS)

[madras50]

yeah but the wrong way.

[Tdash]

i expected the lunch move at 12.. guess it came a lil early

[crudeoil24]

CHFS wayyyyy oversold!

[Tdash]

The 12pm move will be interesting to see

[crudeoil24]

Also, big catalysts here, both fundamental and technical.

[crudeoil24]

Investors are forward looking. Folks are encouraged by FDA giving the green light. Financially company on solid footing.

[crudeoil24]

Shorts do not like HIGH VOLUME, SUPER LOW FLOATERS!!!!!

[Tim696969]

Indeed! They have cash to fund operations through Q1 2018! "Completed a warrant exercise agreement to incent exercise of warrants for cash which netted approximately $1.8 million in cash proceeds. Subsequent to quarter end, completed an underwritten public equity offering for net proceeds of approximately $8.1 million, following which we believe we have sufficient cash to fund our operations through the first quarter of 2018."

[UP Trend]

When it's this easy you know it's going much higher:)

[Tdash]

was easy money here

[jr525]

Soooo... how many times was the float traded in a hr lol.... only going higher

[crudeoil24]

CHF Solutions' Aquadex FlexFlow(R) Aquapheresis System Receives FDA IDE Approval for Clinical Study for Pediatric Use
1 day 3 hours 19 minutes ago - DJNF

CHF Solutions' Aquadex FlexFlow(R) Aquapheresis System Receives FDA IDE Approval for Clinical Study for Pediatric Use
EDEN PRAIRIE, Minn., June 29, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc., (fka Sunshine Heart, Inc.) (NASDAQ:CHFS) announced today that researchers in the Stanford University School of Medicine's Department of Pediatrics have received FDA Investigational Device Exemption (IDE) approval to conduct a clinical study to evaluate the safety and effectiveness of CHF Solutions' Aquadex FlexFlow Aquapheresis System for diuretic-resistant fluid overload in children with acute decompensated heart failure. The randomized multi-center, non-blinded clinical study will assess up to 45 children and young adults ages 6 months to 21 years with heart failure and diuretic-resistant fluid overload. Heart failure is the leading cause of death in children with cardiomyopathy and congenital heart disease.

The study seeks to determine whether Aquapheresis therapy is associated with greater weight loss and a non-inferior rate of renal dysfunction compared to optimal medical therapy. In addition, the impact on heart failure symptoms using a novel pediatric heart failure symptoms score developed by the investigators, adverse outcomes and the need for medical management will be evaluated as secondary endpoints. The study is being led by Stanford's Christopher Almond, Associate Professor of Pediatrics (Cardiology), and David Kwiatkowski, Clinical Assistant Professor of Pediatrics (Cardiology).

"We are pleased that the researchers have received FDA approval to proceed with this IDE study," said John Erb, Chairman and CEO of CHF Solutions. "Given the limitations of patient unresponsiveness to diuretic therapies over time, our solution represents a potentially transformative future standard of care. We look forward to the clinical data results and to continuing our efforts to provide patients with additional treatment options for the treatment of heart failure," Mr. Erb concluded.

[crudeoil24]

With today's news, trending back to $8.00+
CHFS

[crudeoil24]

CHFS is a great $$$$$ opportunity.

[crudeoil24]

I p/u some 1.34's

[stockdawg44]

srsc too, low float, playing both now....heads up

[stockdawg44]

looking good here w support and breaking resit....

[crudeoil24]

CHFS > SUPER LOW FLOAT!!!!!

[UP Trend]

This one will be epic, FDA news, low floater and most of float locked up yesterday. Float so small even little guys can lock it down.. 2s en route!

[shurtha2000]

another multi day runner like AVEO and SPEX

[UP Trend]

2 million volume PM already, gonna be a fun day:)

[easymoney]

You too!!, thx.

[Ericj5592]

Only $1.14

[Ericj5592]

Great opportunity to jump in ladies and gentlemen

[dollardeadline]

have a good day and 4th holiday bro

[dollardeadline]

same On DXt$ here

[easymoney]

I looked at it a few days ago thanks, focusing on otc now as I traded MAR$ few times and only holding Dxt$ for now.

Thanks

[dollardeadline]

Hey easy , check Eye's chart ta...https://flyzoo.blob.core.windows.net/uploads/59556ed4bb547f2474f7ff2e-screen-shot-2017-06-29-at-21851-pm.png

[stock1ace1]

Yup great play guys $$

[georgie18]

CHFS...$1.37...great move in pre market...

[easymoney]

Sorry to early, 1.3 and 1.6.

[easymoney]

3.6 if I recall,lower 3.3.

[OTCWealth101]

And what is that?

[easymoney]

I like it to fill the upper gap tomorrow .

[jr525]

My 10k shares looking mighty great at .76

[georgie18]

Beauty from 75 alert...looking to fill that gap down on a gappa tomorrow...

[goodword88]

So many got in over .90. It will have to go a bit higher to make dumping profitable. Unless you bought a bunch of shares at .10 last week people may stay in a little longer.

[UP Trend]

Beautiful close, starting to SPEX their muscle.

[Ericj5592]

Tomorrow I'm jumping in with $1.5k

[Crackers07]

True but i would not play this as a long term. This is a day trade at best.

[UP Trend]

Tiny tiny float + green light from FDA = perfect storm:)

[Crackers07]

This is not fda approval for a product, this is to start clinical trials.

https://www.streetinsider.com/Corporate+News/CHF+Solutions+%28CHFS%29+Granted+FDA+IDE+Approval+for+Clinical+Study+Aquadex+FlexFlow+Aquapheresis+System+for+Pediatric+Use/13056574.html

[Crackers07]

FDA approval for clinical trials no products were actually FDA approved this is a pump and dump. What a turd of a stock.

[wantabetrader]

Train is getting ready to go

[wantabetrader]

Load now while it's under a buck
Imo it's about to fly

[Tdash]

I appreciate it lol.

[jr525]

Your welcome lol

[Tdash]

I guess the key word to get the stock moving to QUIET BOARD.. lol it ran up pass the high since then..

[UP Trend]

Dollar Hollar! 10 big boys pickup 100k shares each and float is locked down.

[wantabetrader]

Break that .95 looks clear to 1.50
Imo